NVACW — Profusa, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1859807 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | 0 | -4,006,000 | -3,456,000 | 862,000 | 375,000 | 29,060,000 |
| Sep 2025 | 0 | 0 | -21,709,000 | -22,192,000 | 4,250,000 | 3,009,000 | 38,210,000 |
| Jun 2025 | 15,159 | 0 | -967,084 | -8,196,876 | 1,962,416 | — | 23,142,121 |
| Mar 2025 | 79,925 | 0 | -583,581 | -1,119,910 | 1,983,584 | — | 14,298,791 |
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -27,706,000 | -35,823,000 | 3,775,000 | 30,433,000 | -26,658,000 | — |
| Dec 2024 | 425,416 | -1,351,038 | -8,711,619 | 8,391,697 | 13,011,056 | -4,619,359 | — |
| Dec 2023 | 2,248,538 | -1,508,683 | 1,161,910 | 10,884,675 | 5,091,777 | 5,792,898 | — |
| Dec 2022 | -2,579,268 | -1,270,554 | 7,167,738 | 194,736,486 | 1,830,478 | 192,906,008 | — |
| Dec 2021 | — | — | — | 193,060,803 | 7,322,533 | 185,738,270 | — |
TTM Snapshot
Revenues TTM
$-79,925
NetIncome TTM
$-38,159,090
OpCashFlow TTM
—
Assets (Latest)
$862,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $148.83B | $415.41 | — |
| MDT | Medtronic plc | $112.24B | $87.75 | — |
| SYK | STRYKER CORP | $106.24B | $276.97 | — |
| MMM | 3M CO | $84.36B | $163.58 | — |
| BSX | BOSTON SCIENTIFIC CORP | $60.93B | $42.04 | — |
News headlines (Yahoo Finance, 1h cache)
Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark
2026-09-24 15:01 · Yahoo
Profusa, Inc. Receives Nasdaq Compliance Determination
2026-09-15 10:00 · Yahoo
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
2026-08-31 12:50 · Yahoo
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens
2026-08-20 14:49 · Yahoo
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
2026-08-20 12:30 · Yahoo
Profusa Announces 1-for-4 Reverse Stock Split
2026-08-13 11:00 · Yahoo
Profusa vies for potential G3 Vision Labs acquisition
2026-08-03 11:17 · Yahoo
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
2026-07-31 21:15 · Yahoo
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes
2026-07-27 14:38 · Yahoo
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
2026-07-27 10:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.